l carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to JCI - l-Carnitine in omnivorous
JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism Emerging role of trimethylamine N oxide (TMAO) in colorectal cancer Applied Microbiology and Biotechnology Springer Nature Link Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect Meat metabolizing bacteria in atherosclerosis Nature Medicine
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




